| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |